Form 4: Precipio Inc. Director Cohen David Seth Reports Option Repricing

Director Cohen David Seth reports repricing of stock options at Precipio, Inc. effective August 31, 2024.

Summary

• David Seth Cohen, a director at Precipio, Inc., filed a Form 4 detailing changes in beneficial ownership due to an option repricing.
• The repricing, approved by the Issuer's Board of Directors on August 30, 2024, became effective on August 31, 2024.
• The exercise price of the options was adjusted to $6.56 per share, reflecting the fair market value of Precipio's common stock on the effective date.
• The repriced options will revert to their original exercise price if Cohen's service with the Issuer is terminated with cause or by Cohen, or if the option is exercised, prior to the first anniversary of the effective date.
• The stock options were issued under the Company's Amended and Restated 2017 Stock Option and Incentive Plan and become exercisable according to the vesting schedule in the award agreement.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The repricing could be seen as mildly positive as it aims to incentivize a key director, but it also suggests the stock price may have underperformed expectations.

Positives

• The option repricing may incentivize the director to remain with the company.
• The new exercise price reflects the current fair market value of the company's common stock.

Risks

• The repriced options could revert to their original exercise price if certain conditions are met before the first anniversary of the effective date, potentially demotivating the director.

Industry Context

Option repricing is a common practice to incentivize employees or directors, especially when the stock price has declined below the original option exercise price. This ensures that the options remain a valuable incentive.

Comparison to Industry Standards

• Option repricing is a fairly common practice, especially in volatile sectors like biotechnology, where Precipio operates.
• Companies like Myriad Genetics and Exact Sciences have also used option repricing to retain key personnel during periods of stock price decline.
• The specific terms of the repricing, such as the reversion clause, are company-specific and depend on the individual's role and performance.

Stakeholder Impact

• Shareholders may view the option repricing as a positive move to retain key personnel.
• Employees may see this as a sign that the company is committed to incentivizing its leadership.

Key Dates

Keywords

Form 4, Precipio Inc., Option Repricing, Beneficial Ownership, Director, Cohen David Seth, Stock Options